COLUMN GROUP III GP, LP
SEC CIK 1790965 · EDGAR
BoughtSold
Most active insiders at SRZN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TCG Crossover GP II, LLC | 10% | — | $6.91M |
| 2 | Kutzkey Tim | Dir, 10% | $5.98M | — |
| 3 | COLUMN GROUP III GP, LP | 10% | $4.99M | — |
| 4 | TCG Crossover Fund II, L.P. | 10% | $4.68M | — |
| 5 | Column Group Opportunity III GP, LP | 10% | $641.6K | — |
| 6 | TCG Opportunity III GP, LLC | 10% | $357.3K | — |
| 7 | TCG Crossover GP III, LLC | 10% | $202.5K | — |
| 8 | Parker Craig C | CEO, Dir | — | $150.8K |
| 9 | Williams Charles O | COO | — | $99.0K |
| 10 | Li Yang | Exec. VP, Research | — | $75.0K |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-01-08 | 2026-01-06 | SRZN | Surrozen, Inc./DE | COLUMN GROUP III GP, LP | 10% | P - Purchase | $19.89 | +15.1K | 989.9K | +2% | +$300.3K |
| MI | 2025-12-08 | 2025-12-04+ | SRZN | Surrozen, Inc./DE | COLUMN GROUP III GP, LP | 10% | P - Purchase | $19.22 | +36.1K | 981.9K | +4% | +$694.8K |
| MI | 2025-11-17 | 2025-11-13 | SRZN | Surrozen, Inc./DE | COLUMN GROUP III GP, LP | 10% | P - Purchase | $12.65 | +315.5K | 852.5K | +59% | +$3.99M |
| DMI | 2024-04-08 | 2024-04-04 | SRZN | Surrozen, Inc./DE | COLUMN GROUP III GP, LP | 10% | P - Purchase | $15.50 | +193.5K | 294.8K | +191% | +$3.00M |
| I | 2023-01-23 | 2023-01-19 | TNYA | Tenaya Therapeutics, Inc. | COLUMN GROUP III GP, LP | 10% | P - Purchase | $2.50 | +69.7K | 9.87M | +0.7% | +$174.3K |
| MI | 2023-01-19 | 2023-01-17+ | TNYA | Tenaya Therapeutics, Inc. | COLUMN GROUP III GP, LP | 10% | P - Purchase | $2.51 | +185.2K | 9.66M | +2% | +$465.1K |
Purchase Sale Sale after option exercise All abbreviations